SavedAdd your journal

Journals / Journal of Clinical and Analytical Medicine / 2013 / Cilt: 4 - Sayı: 6

Antiplatelet İlaç Alan Hastalarda Ekstrakorporeal Şok Dalgası ile Litotripsi

Extracorporeal Shock Wave Lithotripsy in Patients Taking Antiplatelet Agents

Cevahir ÖZER
Sezgin GÜVEL
Pages
518–521
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this article was to review the management of extracorporeal shock wave lithotripsy in patients taking antiplatelet agents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Continuation of antiplatelet agents during extracorporeal shock wave lithotripsy may lead to increased risk of procedure-related bleeding.
📊
Key Findings & Data:However,temporary interruption of these agents increases the risk of thromboticevent.
💡
Conclusion & Impact:The aim of this article was to review the management of extracorporeal shock wave lithotripsy in patients taking antiplatelet agents.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Continuation of antiplatelet agents during extracorporeal shock wave lithotripsy may lead to increased risk of procedure-related bleeding. However,temporary interruption of these agents increases the risk of thromboticevent. The aim of this article was to review the management of extracorporeal shock wave lithotripsy in patients taking antiplatelet agents.

Özet

Ekstrakorporeal şok dalgası ile litotripsi sırasında antiplatelet ilaçlara devamedilmesi işleme bağlı kanama riskinde artışa neden olabilir. Bununla birlikte,bu ilaçlara geçici olarak ara verilmesi trombotik olay riskini arttırır. Bu yazının amacı antiplatelet ilaç kullanan hastalarda ekstrakorporeal şok dalgası ilelitotripsi yönetimini gözden geçirmektir.

🔖

Cite This Article

ÖZER, C., GÜVEL, S. (2022). Antiplatelet İlaç Alan Hastalarda Ekstrakorporeal Şok Dalgası ile Litotripsi. Journal of Clinical and Analytical Medicine, Cilt: 4 - Sayı: 6, 518–521. https://ajindex.com/articles/561293

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Tiselius HG. Epidemiology and medical management of stone disease. BJU Int 2003;91(8):758-67
  2. Trinchieri A. Epidemiology of urolithiasis. Clin Cases Miner Bone Metab 2008;5(2):101-6
  3. Alsaikhan B, Andonian S. Shock wave lithotripsy in patients requiring anticoagu- lation or antiplatelet agents. Can Urol Assoc J 2011;5(1):53-7
  4. Li JJ. Inflammation in coronary artery diseases. Chin Med J (Engl) 2011;124(21):3568-75
  5. Behan MW, Storey RF. Antiplatelet therapy in cardiovascular disease. Postgrad Med J 2004;80(941):155-64
  6. Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg 2011;12(2):292-318
  7. Dineen PF, Curtin RJ, Harty JA. A review of the use of common antiplatelet agents in orthopaedic practice. J Bone Joint Surg Br 2010;92(9):1186-91
  8. O’Riordan JM, Markey RJ, Blake G, O’Connell PR. Antiplatelet agents in the peri- operative period. Arch Surg 2009;144(1):69-76
  9. Ueno M, Kodali M, Tello-Montoliu A, Angiolillo DJ. Role of platelets and antipla-telet therapy in cardiovascular disease. J Atheroscler Thromb 2011;18(6):431-42
  10. Michelson AD. Advances in antiplatelet therapy. Hematology Am Soc Hematol Educ Program 2011;2011(1):62-9
  11. Norris JW. Antiplatelet agents in secondary prevention of stroke: a perspective. Stroke 2005;36(9):2034-6
  12. Kolandaivelu K, Bhatt DL. Antiplatelet therapy in coronary heart disease prevention. Cardiol Clin 2011;29(1):71-85
  13. Thachil J, Gatt A, Martlew V. Managemant of surgical patients receiving antico- agulation and antiplatelet agents. Br J Surg 2008;95(12):1437-48
  14. Chassot PG, Marcucci C, Delabays A, Spahn DR. Perioperative antiplatelet therapy. Am Fam Physician 2010;82(12):1484-9
  15. Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithot- ripsy 25 years later: complications and their prevention. Eur Urol 2006;50(5):981- 90
  16. Turna B, Stein RJ, Smaldone MC, Santos BR, Kefer JC, Jackman SV, et al. Safety and efficacy of flexible ureterorenoscopy and holmium:YAGlithotripsy for intrarenal stones in anticoagulated cases. J Urol 2008;179(4):1415-9
  17. Collet JP, Montalescot G. Premature withdrawal and alternative therapies to dual oral antiplatelet therapy. Eur Heart J 2006;8(Suppl.G):G46-52
  18. Silberstein J, Lakin CM, Kellogg Parsons J. Shock wave lithotripsy and renal hemorrhage.Rev Urol 2008;10(3):236-41.